Author

A. Ploquin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:non-human primate· 3 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

K. E. Foulds· 3 shared D. A. Stanley· 2 shared D. Carr· 2 shared J. B. Geisbert· 2 shared J. I. Moliva· 2 shared L. Wang· 2 shared N. J. Sullivan· 2 shared R. Hunegnaw· 2 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

K. E. Foulds

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Single-shot ChAd3 Vaccine Provides Protection from Intramuscular and Aerosol Sudan Virus Exposure

A. N. Honko, R. Hunegnaw, J. I. Moliva, A. Ploquin, C. N. M. Dulan, T. Murray, D. Carr, K. E. Foulds, J. B. Geisbert, T. W. Geisbert, J. C. Johnson, S. E. Wollen-Roberts, J. C. Trefry, D. A. Stanley, N. J. Sullivan

A single dose of ChAd3-SUDV vaccine protected macaques from lethal SUDV challenge via parenteral and aerosol routes.

bioRxiv · Feb 7, 2024 · PreprintImmunology

Rapid and Durable Protection Against Marburg Virus with a Single-Shot ChAd3-MARV GP Vaccine

R. Hunegnaw, A. Honko, L. Wang, D. Carr, T. Murray, W. Shi, C. N. M. Dullan, K. E. Foulds, K. N. Agans, R. W. Cross, J. B. Geisbert, T. W. Geisbert, C. Cheng, A. Ploquin, D. A. Stanley, , N. J. Sullivan

A single-shot ChAd3-MARV vaccine provided rapid and durable protection against lethal Marburg virus infection in macaques, with antigen-specific antibodies correlating strongly with immunity.

bioRxiv · Dec 22, 2021 · PreprintImmunology

Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway

M. Gagne, K. S. Corbett, B. J. Flynn, K. E. Foulds, D. A. Wagner, S. F. Andrew, J.-P. M. Todd, C. C. Honeycutt, L. McCormick, S. T. Nurmukhambetova, M. E. Davis-Gardner, L. Pessaint, K. W. Bock, B. M. Nagata, M. Minai, , B. S. Graham

This study shows that mRNA-1273 vaccine protection against SARS-CoV-2 Delta in nonhuman primates persists for one year but is delayed and relies on anamnestic antibody responses in the lower airway.

bioRxiv · Oct 23, 2021 · PreprintImmunology